It is widely believed that oncogene products alter growth regulation of cells by interacting with the machinery controlling normal growth and metabolism. Although src was the first oncogene to be identified at the molecular level, there have been few detailed investigations of the effects of pp60v-src on the molecular machinery of growth control. During the previous grant period we investigated the effects of src on the EGF receptor, and determine that src expression causes a profound decrease in the number of EGF receptors, largely by inhibiting receptor biosynthesis. During the coming grant period we will analyze at the molecular level the basis for decreased EGF-receptor biosynthesis in src-transformed cells. We also will begin to focus on the insulin family of receptors, since insulin and/or IGFs are required for the growth of the fibroblastic cells which are targets for transformation by src, and because we have evidence that the functioning of these receptors may be altered in src-transformed cells. For these studies, we will take advantage of a large panel of src mutants which have been well defined both biologically and molecularly. Such mutants provide an exceptional opportunity to explore the relationships between oncogene structure, specific phosphorylations and biological phenotype.
Our specific aims are as follows: 1. Down-modulation of the EGF receptor in src-transformed cells. a. Regulation of EGF receptor gene expression. b. Degradation of the EGF receptor. 2. Structure and function of insulin and IGF receptors in src- transformed cells. a. Measurements of receptor amounts and ligand-binding affinities. b. Measurements of receptor kinase activity and phosphorylation state. c. Analysis of the mechanisms of src-induced changes in receptor structure and function. 3. Second messengers in src-transformed cells. a. Turnover of phosphatidyl inositol and the generation of related metabolites. b. Analysis of cAMP levels. c. Investigation of possible mediators of insulin action.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA040042-08
Application #
3795047
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
8
Fiscal Year
1992
Total Cost
Indirect Cost
Name
University of Virginia
Department
Type
DUNS #
001910777
City
Charlottesville
State
VA
Country
United States
Zip Code
22904
Walters, Dustin M; Lindberg, James M; Adair, Sara J et al. (2013) Inhibition of the growth of patient-derived pancreatic cancer xenografts with the MEK inhibitor trametinib is augmented by combined treatment with the epidermal growth factor receptor/HER2 inhibitor lapatinib. Neoplasia 15:143-55
Guerrero, Michael S; Parsons, J Thomas; Bouton, Amy H (2012) Cas and NEDD9 Contribute to Tumor Progression through Dynamic Regulation of the Cytoskeleton. Genes Cancer 3:371-81
Owen, Katherine A; Abshire, Michelle Y; Tilghman, Robert W et al. (2011) FAK regulates intestinal epithelial cell survival and proliferation during mucosal wound healing. PLoS One 6:e23123
Ohama, Takashi; Brautigan, David L (2010) Endotoxin conditioning induces VCP/p97-mediated and inducible nitric-oxide synthase-dependent Tyr284 nitration in protein phosphatase 2A. J Biol Chem 285:8711-8
Hall, Emily H; Balsbaugh, Jeremy L; Rose, Kristie L et al. (2010) Comprehensive analysis of phosphorylation sites in Tensin1 reveals regulation by p38MAPK. Mol Cell Proteomics 9:2853-63
Hall, Emily H; Daugherty, Abbi E; Choi, Colin K et al. (2009) Tensin1 requires protein phosphatase-1alpha in addition to RhoGAP DLC-1 to control cell polarization, migration, and invasion. J Biol Chem 284:34713-22
Molhoek, Kerrington R; McSkimming, Chantel C; Olson, Walter C et al. (2009) Apoptosis of CD4(+)CD25(high) T cells in response to Sirolimus requires activation of T cell receptor and is modulated by IL-2. Cancer Immunol Immunother 58:867-76
Slack-Davis, Jill K; Hershey, E Daniel; Theodorescu, Dan et al. (2009) Differential requirement for focal adhesion kinase signaling in cancer progression in the transgenic adenocarcinoma of mouse prostate model. Mol Cancer Ther 8:2470-7
Tilghman, Robert W; Parsons, J Thomas (2008) Focal adhesion kinase as a regulator of cell tension in the progression of cancer. Semin Cancer Biol 18:45-52
Vomastek, Tomas; Iwanicki, Marcin P; Burack, W Richard et al. (2008) Extracellular signal-regulated kinase 2 (ERK2) phosphorylation sites and docking domain on the nuclear pore complex protein Tpr cooperatively regulate ERK2-Tpr interaction. Mol Cell Biol 28:6954-66

Showing the most recent 10 out of 222 publications